Clinical trial · Observational
Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids
NCT02819609CI-TRIAL-00022781completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this observational, retrospective database study of patients with uterine fibroids is to compare the durability of symptom relief after uterus-conserving treatments for symptomatic fibroids in terms of incidence of, and time to, new or recurrent symptoms and subsequent procedures and evaluate the effect stakeholder participation had on the research process.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Fibroids | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| endometrial ablation | Procedure | — | UNRESOLVED |
| MRI-guided focused ultrasound ablation | Procedure | — | UNRESOLVED |
| myomectomy | Procedure | — | UNRESOLVED |
| uterine artery embolization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Myomectomy
- description
- Women with uterine fibroids who underwent myomectomy as their index procedure as part of their routine clinical care
- interventionNames
- Procedure: myomectomy
- label
- Endometrial ablation
- description
- Women with uterine fibroids who underwent endometrial ablation as their index procedure as part of their routine clinical care
- interventionNames
- Procedure: endometrial ablation
- label
- Uterine artery embolization
- description
- Women with uterine fibroids who underwent uterine artery embolization as their index procedure as part of their routine clinical care
- interventionNames
- Procedure: uterine artery embolization
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 54 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients with a diagnosis of uterine fibroids at any time and at least 1 office visit during study time period * At least 1 of the procedures of interest occurring between January 1, 2005 - December 31, 2011 * ≥ 18 years and \< 55 years of age at the index date Exclusion Criteria: * Patients with a diagnosis of gynecologic cancer (ovarian, uterine, cervical) * First recorded diagnosis of uterine fibroids occurring beyond four weeks after the Index Date ONLY for patients who underwent endometrial ablation or hysterectomy * Patients with a record of any procedures of interest occurring before January 1, 2005
References
Publications (0)
Data not yet available
No reference posted for this study.